vs

Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $13.8M, roughly 1.2× CB Financial Services, Inc.). On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 19.9%).

CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

CBFV vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
1.2× larger
SLGL
$17.3M
$13.8M
CBFV
Growing faster (revenue YoY)
SLGL
SLGL
+197.8% gap
SLGL
217.7%
19.9%
CBFV

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CBFV
CBFV
SLGL
SLGL
Revenue
$13.8M
$17.3M
Net Profit
$11.6M
Gross Margin
Operating Margin
38.1%
65.1%
Net Margin
67.3%
Revenue YoY
19.9%
217.7%
Net Profit YoY
487.6%
EPS (diluted)
$0.90
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBFV
CBFV
SLGL
SLGL
Q4 25
$13.8M
Q3 25
$2.4M
Q2 25
$13.5M
$17.3M
Q1 25
$12.1M
Q4 24
$13.2M
Q3 24
$12.7M
Q2 24
$12.2M
$5.4M
Q1 24
$13.5M
Net Profit
CBFV
CBFV
SLGL
SLGL
Q4 25
Q3 25
$-5.7M
Q2 25
$3.9M
$11.6M
Q1 25
$1.9M
Q4 24
Q3 24
$3.2M
Q2 24
$2.6M
$2.0M
Q1 24
$4.2M
Operating Margin
CBFV
CBFV
SLGL
SLGL
Q4 25
38.1%
Q3 25
-289.8%
Q2 25
35.0%
65.1%
Q1 25
19.3%
Q4 24
23.1%
Q3 24
31.2%
Q2 24
26.4%
29.9%
Q1 24
37.9%
Net Margin
CBFV
CBFV
SLGL
SLGL
Q4 25
Q3 25
-235.2%
Q2 25
29.3%
67.3%
Q1 25
15.8%
Q4 24
Q3 24
25.3%
Q2 24
21.8%
36.4%
Q1 24
31.1%
EPS (diluted)
CBFV
CBFV
SLGL
SLGL
Q4 25
$0.90
Q3 25
$-1.07
Q2 25
$0.74
$4.17
Q1 25
$0.35
Q4 24
$0.45
Q3 24
$0.60
Q2 24
$0.51
$0.71
Q1 24
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBFV
CBFV
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$31.7M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$157.5M
$31.9M
Total Assets
$1.5B
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBFV
CBFV
SLGL
SLGL
Q4 25
$31.7M
Q3 25
$55.9M
Q2 25
$64.5M
$24.3M
Q1 25
$61.3M
Q4 24
$49.6M
Q3 24
$147.3M
Q2 24
$142.6M
$26.5M
Q1 24
$73.7M
Stockholders' Equity
CBFV
CBFV
SLGL
SLGL
Q4 25
$157.5M
Q3 25
$152.5M
Q2 25
$148.4M
$31.9M
Q1 25
$148.3M
Q4 24
$147.4M
Q3 24
$149.1M
Q2 24
$142.9M
$34.9M
Q1 24
$141.6M
Total Assets
CBFV
CBFV
SLGL
SLGL
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.5B
$39.3M
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.6B
$42.0M
Q1 24
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBFV
CBFV
SLGL
SLGL
Operating Cash FlowLast quarter
$17.8M
Free Cash FlowOCF − Capex
$17.2M
FCF MarginFCF / Revenue
124.1%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBFV
CBFV
SLGL
SLGL
Q4 25
$17.8M
Q3 25
$4.6M
Q2 25
$4.1M
Q1 25
$4.0M
Q4 24
$6.8M
Q3 24
$3.1M
Q2 24
$-1.2M
Q1 24
$3.3M
Free Cash Flow
CBFV
CBFV
SLGL
SLGL
Q4 25
$17.2M
Q3 25
$4.5M
Q2 25
$3.9M
Q1 25
$3.9M
Q4 24
$3.4M
Q3 24
$2.2M
Q2 24
$-2.4M
Q1 24
$2.3M
FCF Margin
CBFV
CBFV
SLGL
SLGL
Q4 25
124.1%
Q3 25
186.5%
Q2 25
28.8%
Q1 25
32.5%
Q4 24
26.0%
Q3 24
17.4%
Q2 24
-19.6%
Q1 24
17.0%
Capex Intensity
CBFV
CBFV
SLGL
SLGL
Q4 25
4.7%
Q3 25
4.3%
Q2 25
1.9%
Q1 25
0.8%
Q4 24
25.1%
Q3 24
6.7%
Q2 24
10.0%
Q1 24
7.2%
Cash Conversion
CBFV
CBFV
SLGL
SLGL
Q4 25
Q3 25
Q2 25
1.05×
Q1 25
2.11×
Q4 24
Q3 24
0.95×
Q2 24
-0.44×
Q1 24
0.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons